Transfusion in the operating room and the intensive care unit: Current practice and future directions

International Anesthesiology Clinics

Volumn 38, Issue 4, 2000, Pages 149-169

  Wall, M H ^a   Prielipp, R C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; FRESH FROZEN PLASMA;

ANAPHYLAXIS; ANESTHESIOLOGICAL TECHNIQUES; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL PRACTICE; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION RISK; INTENSIVE CARE; LUNG INJURY; OPERATING ROOM; PRIORITY JOURNAL; REVIEW; THROMBOCYTE TRANSFUSION; TREATMENT INDICATION;

EID: 0033777361     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-200010000-00011     Document Type: Review

References (66)

1. Perioperative red blood cell transfusion
2. Practice strategies for elective red blood cell transfusion. American College of Chest Physicians
3. Practice guidelines for blood component therapy: A report by the
4. Guidelines for red blood cell and plasma transfusion in adults and children
5. Consensus statement on red cell transfusion
6. Catecholamines and regional hemodynamics during isovolemic hemodilution in anesthetized pigs
7. Effect of increased blood fluidity through hemodilution on general circulation at rest and during exercise in dogs
8. Physiologic effects of acute anemia: Implications for a reduced transfusion trigger
9. Profound hemodilution: What is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human?
10. Oxygen consumption and cardiovascular function in children during profound intraoperative normovolemic hemodilution
11. Management of severe anemia without transfusion in a pediatric Jehovah's Witness patient
12. Human cardiovascular and metabolic response to acute, severe isovolemic anemia
13. -1
14. Coronary and cardiovascular dynamics and oxygen availability during acute normovolemic anemia
15. Graded coronary stenosis and coronary flow during acute normovolemic anemia
16. Response of the hypertrophied heart to acute anemia and coronary stenosis
17. Acute isovolemic hemodilution and blood transfusion. Effects on regional function and metabolism in myocardium with compromised coronary blood flow
18. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity
19. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit
20. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy
21. Silent myocardial ischaemia in a patient with anaemia before operation
22. Optimal hematocrit value in critically ill postoperative patients
23. Cardiovascular and metabolic response to red blood cell transfusion in critically ill volume-resuscitated nonsurgical patients
24. Blood transfusion and oxygen consumption in surgical sepsis
25. Reevaluation of current transfusion practices in patients in surgical intensive care units
26. Effects of blood transfusion on oxygen transport variables in severe sepsis
27. Effect of transfusion on oxygen transport in critically ill patients
28. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis
29. Association of mortality with age of blood transfused in septic ICU patients
30. Does transfusion practice affect mortality in critically ill patients?
31. Perioperative blood transfusion and postoperative mortality
32. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease
33. Limitations of blood conservation
34. Comparison of two transfusion strategies after elective operations for myocardial revascularization
35. Effect of early blood transfusion on gastrointestinal haemorrhage
36. Transfusion requirements in critical care: A pilot study
37. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care
38. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities
39. Central venous catheter placement in patients with disorders of hemostasis
40. Central venous catheterization in patients with coagulopathy
41. Platelet transfusion therapy
42. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets
43. Platelet transfusion: Final statement
44. Fresh-frozen plasma. Indications and risks
45. Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology
46. The anti-inflammatory properties of antithrombin III: New therapeutic implications
47. Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure
48. Anti-thrombin III in patients with severe sepsis: A randomized placebo-controlled double blind multicenter trial
49. Transfusion medicine. First of two parts - Blood transfusion
50. The risk of transfusion-transmitted viral infections
51. The significance of hepatitis G virus in serum of patients with sporadic fulminant and subfulminant hepatitis of unknown etiology
52. Natural history of the TT virus infection through follow-up of TTV DNA-positive multiple-transfused patients
53. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans
54. The pathology of transfusion-related acute lung injury
55. Transfusion-associated graft-versus-host disease: Historical perspectives, incidence, and current use of irradiated blood products
56. Immunomodulatory aspects of transfusion: A once and future risk?
57. New transfusion strategies: Red cell substitutes
58. Modified hemoglobin-based blood substitutes: Crosslinked, recombinant and encapsulated hemoglobin
59. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke
60. Perfluorocarbon compounds
61. Hemoglobin-based oxygen-carrying solutions: Close but still so far
62. The use of quality control of leukocyte-depleted cell concentrates
63. Use of irradiated blood components: Practice parameter
64. Current status of solvent/detergent-treated frozen plasma